Mirabella Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

Mirabella Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,377	Closed	-$2.1M	–	795
2025 Q3	$2.1M	Buy	5,377 +3,078	+134%	+$1.29M	0.18%	121
2025 Q2	$1.03M	Sell	2,299 -111,467	-98%	-$51.4M	0.11%	134
2025 Q1	$55.3M	Buy	113,766 +102,582	+917%	+$47.8M	1.11%	25
2024 Q4	$4.5M	Buy	+11,184	New	+$5.18M	0.41%	54
2023 Q4	–	Sell	-946	Closed	-$329K	–	603
2023 Q3	$329K	Sell	946 -28,089	-97%	-$9.82M	0.05%	267
2023 Q2	$10.2M	Buy	+29,035	New	+$9.78M	1.12%	10
2022 Q2	–	Sell	-2,449	Closed	-$639K	–	730
2022 Q1	$639K	Buy	+2,449	New	+$581K	0.07%	210

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Mirabella Financial Services's VRTX Position: Q4 2025 in Review

Mirabella Financial Services sold out of Vertex Pharmaceuticals (VRTX) in Q4 2025, closing a stake of 5,377 shares — an estimated $2.1M sold.

Mirabella Financial Services first reported a position in VRTX in Q1 2022 and held it in 7 quarters. The position peaked at $55.3M in Q1 2025. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

Mirabella Financial Services reported no remaining Vertex Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Mirabella Financial Services sold 5,377 Vertex Pharmaceuticals shares in Q4 2025, an estimated $2.1M.
Mirabella Financial Services first reported a position in Vertex Pharmaceuticals in Q1 2022 and held it in 7 quarters.
Mirabella Financial Services's Vertex Pharmaceuticals position peaked at $55.3M in Q1 2025.
1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Mirabella Financial Services's 13F filing for Q4 2025, filed 17 Feb 2026.